Evidence map›Paper›PMID 36213331›Full record

ArticleEuropean heart journal open2022

Chronic kidney disease in patients with congenital heart disease: a nationwide, register-based cohort study.

Mikaela Gillesén, Maria Fedchenko, Kok Wai Giang, Konstantinos Dimopoulos, Peter Eriksson, Mikael Dellborg, Zacharias Mandalenakis

Open access · goldAbstract read
In one paragraph

Article in European heart journal open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. SomaticExperimental and therapeutic medicine · 2024
    Article
  10. Discovery and functional investigation ofAmerican journal of translational research · 2024
    Article
  11. Discovery ofAmerican journal of translational research · 2024
    Article
  12. Discovery ofBiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mikaela GillesénDepartment of Molecular & Clinical Medicine/Cardiology, Sahlgrenska Academy, University of Gothenburg, Blå stråket 5B, SE-41345 Gothenburg, Sweden.ORCID https://orcid.org/0000-0003-0310-2400
Maria FedchenkoDepartment of Molecular & Clinical Medicine/Cardiology, Sahlgrenska Academy, University of Gothenburg, Blå stråket 5B, SE-41345 Gothenburg, Sweden.
Kok Wai GiangDepartment of Molecular & Clinical Medicine/Cardiology, Sahlgrenska Academy, University of Gothenburg, Blå stråket 5B, SE-41345 Gothenburg, Sweden.
Konstantinos DimopoulosAdult Congenital Heart Centre and Centre for Pulmonary Hypertension Royal Brompton Hospital, Guys and St Thomas' NHS Trust, Sydney Street, London SW3 6NP, United Kingdom.
Peter ErikssonDepartment of Molecular & Clinical Medicine/Cardiology, Sahlgrenska Academy, University of Gothenburg, Blå stråket 5B, SE-41345 Gothenburg, Sweden.
Mikael DellborgDepartment of Molecular & Clinical Medicine/Cardiology, Sahlgrenska Academy, University of Gothenburg, Blå stråket 5B, SE-41345 Gothenburg, Sweden.
Zacharias MandalenakisDepartment of Molecular & Clinical Medicine/Cardiology, Sahlgrenska Academy, University of Gothenburg, Blå stråket 5B, SE-41345 Gothenburg, Sweden.
Sahlgrenska University Hospital · SEUniversity of Gothenburg · SERoyal Brompton Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: To investigate the risk of chronic kidney disease (CKD) in young patients with congenital heart disease (CHD) (age 0-47 years) compared with age- and sex-matched controls without CHD. Methods and results: Using data from the Swedish National Patient Register and the Cause of Death Register, 71,936 patients with CHD (50.2% male) born between 1970 and 2017 were identified. Each patient with CHD was matched by sex and age to 10 controls without CHD ( Conclusion: Although the absolute risk of CKD in young patients with CHD is relatively low, patients with CHD are six times more likely to develop CKD than non-CHD controls up to the age of 47 years. Further data are needed to inform guidelines on the prevention and follow-up of CKD in CHD patients.

Indexed as

AdultsChildrenChronic kidney diseaseCongenital heart disease

Identifiers

PMID36213331
PMCPMC9537654
OpenAlexW4294295858

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.